416 related articles for article (PubMed ID: 8968501)
21. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium.
Rousseau E; Gagnon J; Lugnier C
Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
[No Abstract] [Full Text] [Related]
23. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
24. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
Hoskins B; Luong HB
Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
[TBL] [Abstract][Full Text] [Related]
25. Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.
Houslay MD; Scotland G; Erdogan S; Huston E; Mackenzie S; McCallum JF; McPhee I; Pooley L; Rena G; Ross A; Beard M; Peder A; Begg F; Wilkinson I; Yarwood S; Ackerman C; Houslay ES; Hoffman R; Engels P; Sullivan M; Bolger G
Biochem Soc Trans; 1997 May; 25(2):374-81. PubMed ID: 9191121
[No Abstract] [Full Text] [Related]
26. [Phosphodiesterases of cyclic GMP].
Wróblewska H; Gorczyca WA
Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
[TBL] [Abstract][Full Text] [Related]
27. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
28. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
29. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
30. Cyclic nucleotide phosphodiesterase from Spinacea oleracea L: subcellular distribution and properties [proceedings].
Edwards M; Brown EG; Newton RP; Smith CJ
Biochem Soc Trans; 1977; 5(4):975-7. PubMed ID: 199507
[No Abstract] [Full Text] [Related]
31. Cyclic nucleotide phosphodiesterase activity in the mussel Mytilus edulis L. [proceedings].
Abreu-Grobois FA; Newton RP; Smith CJ
Biochem Soc Trans; 1977; 5(5):1348-51. PubMed ID: 200501
[No Abstract] [Full Text] [Related]
32. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
33. Calmodulin and cyclic nucleotide-phosphodiesterase activities in rat mammary gland during the lactogenic cycle.
Pizarro M; Puente J; Sapag-Hagar M
FEBS Lett; 1981 Dec; 136(1):127-30. PubMed ID: 6274696
[No Abstract] [Full Text] [Related]
34. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
35. The N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activity.
Houslay MD
Biochem Soc Trans; 1996 Nov; 24(4):980-6. PubMed ID: 8968496
[No Abstract] [Full Text] [Related]
36. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
Chini CC; Grande JP; Chini EN; Dousa TP
J Biol Chem; 1997 Apr; 272(15):9854-9. PubMed ID: 9092521
[TBL] [Abstract][Full Text] [Related]
37. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
38. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
39. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
Maurice DH
Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
[TBL] [Abstract][Full Text] [Related]
40. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
Hait WN; Weiss B
Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]